| Patent Number |
Title Of Patent |
Date Issued |
| RE32455 |
A-21978 antibiotics and process for their production |
July 7, 1987 |
| Antibiotic A-21978C complexes, in particular the A-21978C complex, comprising microbiologically active, related factors, C.sub.0, C.sub.1, C.sub.2, C.sub.3, C.sub.4, and C.sub.5. A-21978 complex and A-21978C complex are produced by submerged aerobic fermentation of Streptomyces roseo |
| RE32333 |
A-21978 Antibiotics and process for their production |
January 20, 1987 |
| Antibiotic A-21978 complexes, in particular the A-21978C complex, comprising microbiologically active, related factors C.sub.0, C.sub.1, C.sub.2, C.sub.3, C.sub.4, and C.sub.5. A-21978 complex and A-21978C complex are produced by submerged aerobic fermentation of Streptomyces roseosp |
| RE31396 |
A-21978 Antibiotics and process for their production |
September 27, 1983 |
| Antibiotic A-21978 complexes, in particular the A-21978C complex, comprising microbiologically active, related factors C.sub.0, C.sub.1, C.sub.2, C.sub.3, C.sub.4, and C.sub.5. A-21978 complex and A-21978C complex are produced by submerged aerobic fermentation of Streptomyces roseosp |
| 5239064 |
A59770 antibiotics |
August 24, 1993 |
| A novel antibiotic complex, A59770, individual factors and derivatives thereof, are provided. The A59770 compounds are useful as pesticides, particularly as rodenticides. Further provided are methods for reducing a rodent population, rodenticidal compositions, and an A59770-producing |
| 4994270 |
A54145 antibiotics and process for their production |
February 19, 1991 |
| New peptide antibiotic A54145, individual A54145 components A, A.sub.1, B, B.sub.1, C, D, E and F and their pharmaceutically acceptable salts, are useful antibacterial agents which also improve growth performance in animals, especially poultry. Biologically pure cultures of the A5414 |
| 4717714 |
A-51568B antibiotic |
January 5, 1988 |
| The novel glycopeptide antibiotic A-51568B is produced by submerged, aerobic fermentation of Nocardia orientalis NRRL 15232. A-51568B demonstrates antibiotic activity against gram-positive bacteria. |
| 4558009 |
Process for producing antibiotic A-51568 by fermentation and microorganism |
December 10, 1985 |
| Antibiotic A-51568 is produced by submerged, aerobic fermentation of new Nocardia orientalis NRRL 15232. The antibiotic is effective against gram-positive organisms. |
| 4558008 |
Process for production of A-51568B antibiotic |
December 10, 1985 |
| The novel glycopeptide antibiotic A-51568B is produced by submerged, aerobic fermentation of Nocardia orientalis NRRL 15232. A-51568B demonstrates antibiotic activity against gram-positive bacteria. |
| 4495179 |
A51568 Antibiotic and process for producing thereof |
January 22, 1985 |
| Antibiotic A51568 is produced by submerged, aerobic fermentation of new Nocardia orientalis NRRL 15232. The antibiotic is gram-positive. |
| 4431809 |
Antibiotic A-33853 derivatives |
February 14, 1984 |
| Antibiotic A-33853 is produced by submerged, aerobic fermentation of a new Streptomyces sp. NRRL 12068. The antibiotic and the diacetyl and triacetyl derivatives thereof disclosed herein have shown antibacterial activity against Staphylococcus and Streptococcus species which are penicill |
| 4400510 |
A-32256 Phenazine antibiotic |
August 23, 1983 |
| Antibiotic A-32256 which is produced by submerged, aerobic fermentation of a Streptomyces sp. NRRL 12067. The antibiotic has shown antibacterial activity against Staphylococcus and Streptococcus and various anaerobic species. In addition, the antibiotic has shown antitrichomonas activity |
| 4375462 |
A-32724 Antibiotics and process for production thereof |
March 1, 1983 |
| Antibiotic A-32724 complex, comprising microbiologically-active, related factors A, B and C, is produced by submerged, aerobic fermentation of a strain of Chaetomella raphigera Swift NRRL 12331. The A-32724 antibiotics are closely related antibiotics. The individual A-32724 factors are |
| 4358584 |
Antibiotics A6888C and A6888X |
November 9, 1982 |
| Antibiotic compounds of the formula: ##STR1## wherein R' is ##STR2## or --CH.sub.2 OH, and the non-toxic pharmaceutically acceptable acid addition salts thereof, are produced by culturing Streptomyces flocculus NRRL 11459. Techniques for isolating the compounds are also descr |
| 4336333 |
Process for preparing tunicamycin |
June 22, 1982 |
| Tunicamycin is produced by the cultivation of Streptomyces chartreusis Calhoun and Johnson, 1956, NRRL 12338. Methods of recovering tunicamycin and for separating and isolating individual factors A.sub.1, A.sub.2, B.sub.1, B.sub.2, C.sub.1, C.sub.2, D.sub.1 and D.sub.2 from tunicamycin |
| 4331658 |
Method of treating swine dysentery with antibiotic A-32887 |
May 25, 1982 |
| Method and compositions for treatment of swine dysentery with antibiotic A-32887 (K-41). Antibiotic A-32887 is produced by submerged aerobic fermentation of Streptomyces albus NRRL 11109. |
| 4331594 |
A-21978 Antibiotics and process for their production |
May 25, 1982 |
| Antibiotic A-21978 complexes, in particular the A-21978C complex, comprising microbiologically active, related factors, C.sub.0, C.sub.1, C.sub.2, C.sub.3, C.sub.4, and C.sub.5. A-21978 complex and A-21978C complex are produced by submerged aerobic fermentation of Streptomyces roseos |
| 4329472 |
Antibiotic A-33853 and the tetraacetyl derivative thereof |
May 11, 1982 |
| Antibiotic A-33853 is produced by submerged, aerobic fermentation of a new Streptomyces sp. NRRL 12068. The antibiotic has shown antibacterial activity against Staphylococcus and Streptococcus species which are penicillin resistant. In addition, the antibiotic has shown antirival and |
| 4316959 |
Process for production of antibiotic from streptomyces |
February 23, 1982 |
| Antibiotic A-32256 which is produced by submerged, aerobic fermentation of a Streptomyces sp. NRRL 12067. The antibiotic has shown antibacterial activity against Staphylococcus and Streptococcus and various anaerobic species. In addition, the antibiotic has shown antitrichomonas activity |
| 4303647 |
Method of treating coccidiosis with antibiotic A-32887K |
December 1, 1981 |
| Methods and compositions for treatment of coccidiosis in poultry with antibiotic A-32887 (K-41). Antibiotic A-32887 is produced by submerged aerobic fermentation of Streptomyces albus NRRL 11109. |
| 4293649 |
Process for production of antibiotic A-33853 |
October 6, 1981 |
| Antibiotic A-33853 is produced by submerged, aerobic fermentation of a new Streptomyces sp. NRRL 12068. The antibiotic has shown antibacterial activity against Staphylococcus and Streptococcus species which are penicillin resistant. In addition, the antibiotic has shown antiviral and |
| 4252898 |
Antibiotics A6888C and A6888X |
February 24, 1981 |
| Antibiotic compounds of the formula: ##STR1## wherein R' is ##STR2## or --CH.sub.2 OH, and the non-toxic pharmaceutically acceptable acid addition salts thereof, are produced by culturing Streptomyces flocculus NRRL 11459. Techniques for isolating the compounds are also descr |
| 4208403 |
A-21978 Antibiotics and process for their production |
June 17, 1980 |
| Antibiotic A-21978 complexes, in particular the A-21978C complex, comprising microbiologically active, related factors C.sub.0, C.sub.1, C.sub.2, C.sub.3, C.sub.4, and C.sub.5. A-21978 complex and A-21978C complex are produced by submerged aerobic fermentation of Streptomyces roseosp |
| 4133876 |
Antibiotic A-32887 and process for production thereof |
January 9, 1979 |
| Antibiotic A-32887 is produced by submerged aerobic fermentation of Streptomyces albus NRRL 11109. A-32887 is an antibacterial, antiprotozoal, anticoccidial, and insecticidal agent. A-32887 also increases feed-utilization efficiency in ruminants. |
| 4132778 |
Antibiotic A-32887 |
January 2, 1979 |
| Antibiotic A-32887 is produced by submerged aerobic fermentation of Streptomyces albus NRRL 11109. A-32887 is an antibacterial, antiprotozoal, anticoccidial, and insecticidal agent. A-32887 also increases feed-utilization efficiency in ruminants. |
| 4085224 |
Method of increasing feed utilization |
April 18, 1978 |
| Antibiotic A-28086 complex, comprising microbiologically active, structurally related factors A, B, and D, produced by submerged aerobic fermentation of Streptomyces aureofaciens NRRL 5758. Individual factors A, B, and D are separated and isolated by chromatography. The A-28086 antib |
| 4054564 |
7-(5-Amino-5-carboxyvaleramido)-7-methoxycephalosporanic acid |
October 18, 1977 |
| Antibiotic A16884 and its salts, having antibacterial and anthelmintic activity, prepared by fermentation of Streptomyces lipmanii NRRL 3584. |
| 4038384 |
Antibiotic A-28086 and process for production thereof |
July 26, 1977 |
| Antibiotic A-28086 complex, comprising microbiologically active, structurally related factors A, B, and D, produced by submerged aerobic fermentation of Streptomyces aureofaciens NRRL 5758. Individual factors A, B, and D are separated and isolated by chromatography. The A-28086 antib |
| 4035481 |
Antibiotic A-28086 and process for production thereof |
July 12, 1977 |
| Antibiotic A-28086 complex, comprising microbiologically active, structurally related factors A, B, and D, produced by submerged aerobic fermentation of Streptomyces aureofaciens NRRL 5758. Individual factors A, B, and D are separated and isolated by chromatography. The A-28086 antib |
| 4024245 |
Antibiotic A-30912 and process for production thereof |
May 17, 1977 |
| Antibiotic A-30912 complex, comprising microbiologically active, structurally related factors A, B, C, D, E, F and G, is produced by submerged aerobic fermentation of Aspergillus rugulosus NRRL 8113. The A-30912 factors A, B, C, D, E, F, and G are separated from the A-30912 complex b |
| 4001086 |
Antibiotic A-30641 and process for production thereof |
January 4, 1977 |
| Antibiotic A-30641, a new epidithiodiketopiperazine antifungal agent, is produced together with canadensolide in the A-30641 antibiotic complex by submerged aerobic fermentation of Aspergillus tamarii NRRL 8101. |
| 3991052 |
Antibiotic A-30641 |
November 9, 1976 |
| Antibiotic A-30641, a new epidithiodiketopiperazine antifungal agent, is produced together with canadensolide in the A-30641 antibiotic complex by submerged aerobic fermentation of Aspergillus tamarii NRRL 8101. |
| 3986928 |
Antibiotic A-32390 and process for preparation thereof |
October 19, 1976 |
| Antibiotic A-32390 complex, comprising factor A and other structurally related factors, is produced by cultivation of Pyrenochaeta sp. NRRL 5786 under submerged aerobic conditions, and isolated by extraction of the broth. Individual A-32390 factor A is separated by chromatography. The |
| 3979433 |
1,6-Di-O-(2-isocyano-3-methylcrotonyl)-D-mannitol compounds |
September 7, 1976 |
| Antibiotic A-32390 complex, comprising factor A and other structurally related factors, is produced by cultivation of Pyrenochaeta sp. NRRL 5786 under submerged aerobic conditions, and isolated by extraction of the broth. Individual A-32390 factor A is separated by chromatography. The |
| 3973015 |
Antibiotic A16884 |
August 3, 1976 |
| Antibiotic A16884 and its salts, having antibacterial and anthelmintic activity, prepared by fermentation of Streptomyces lipmanii NRRL 3584. |
| 3960667 |
Antibiotic A23187 and process for preparation thereof |
June 1, 1976 |
| Antibiotic A23187 and process for production thereof by submerged aerobic culture of Streptomyces chartreusis NRRL 3882. The antibiotic demonstrates antimicrobial activity and exhibits ionophorous properties, with a specificity for divalent cations. |
| 3954972 |
Antibiotic A-26771 factor |
May 4, 1976 |
| Antibiotic mixture A-26771, comprising microbiologically active factors A, B and C, produced by fermentation of Penicillium turbatum Westling NRRL 5630, and isolation and separation of the individual factors thereof by extraction, chromatography and crystallization. The A-26771 mixture a |
| 3932219 |
Antibiotic A-26771 factors and process for production thereof |
January 13, 1976 |
| Antibiotic mixture A-26771, comprising microbiologically active factors A, B and C, produced by fermentation of Penicillium turbatum Westling NRRL 5630, and isolation and separation of the individual factors thereof by extraction, chromatography and crystallization. The A-26771 mixture a |